what foods to avoid while on semaglutide What Foods Make You Sick

doi: 10.1016/j.ejphar.2018.10.037 187

Dipeptidyl Peptidase-4 inhibitors Vs

Water(Aqua), C13-15 Alkane, **Niacinamide, Butylene Glycol, Caprylic/Capric Triglyceride, Tranexamic Acid, Glycerin, **Arbutin, 1,2-Hexanediol, **Glutathione, Borago Officinalis Seed Oil, Glycine Soja (Soybean) Seed Extract, **Alpha-Arbutin, **Acetyl Glucosamine, Panthenol, Xanthan Gum, Potassium Cetyl Phosphate, Allantoin, Ethylhexylglycerin, Melia Azadirachta Flower Extract, Disodium EDTA, Ocimum Sanctum Leaf Extract, Polyglutamic Acid, Melia Azadirachta Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Squalane, Sodium Hyaluronate, **Kojic Acid, Ascorbic Acid, Centella Asiatica Extract, Tocopherol, Citrus Limon (Lemon) Fruit Extract, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronate,Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Sodium Hyaluronate Crosspolymer, Polyglyceryl-10 Laurate, Potassium Hyaluronate, Phosphatidylcholine, Tocopheryl AcetateWater(Aqua), C13-15 Alkane, **Niacinamide, Butylene Glycol, Caprylic/Capric Triglyceride, Tranexamic Acid, Glycerin, **Arbutin, 1,2-Hexanediol, **Glutathione, Borago Officinalis Seed Oil, Glycine Soja (Soybean) Seed Extract, **Alpha-Arbutin, **Acetyl Glucosamine, Panthenol, Xanthan Gum, Potassium Cetyl Phosphate, Allantoin, Ethylhexylglycerin, Melia Azadirachta Flower Extract, Disodium EDTA, Ocimum Sanctum Leaf Extract, Polyglutamic Acid, Melia Azadirachta Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Squalane, Sodium Hyaluronate, **Kojic Acid, Ascorbic Acid, Centella Asiatica Extract, Tocopherol, Citrus Limon (Lemon) Fruit Extract, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronate,Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Sodium Hyaluronate Crosspolymer, Polyglyceryl-10 Laurate, Potassium Hyaluronate, Phosphatidylcholine, Tocopheryl Acetate

They found that, as first-line agents, SGLT2is and GLP-1RAs would improve T2DM outcomes, but their costs would need to fall by at least 70% to be cost-effective [84]